Form 10Q
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                   Quarterly Report Under Section 13 or 15 (d)
                     of the Securities Exchange Act of 1934

For Quarter Ended: Feb. 28, 1999              
                 
Commission File Number: 0-11050                            
                       
                              Mammatech Corporation
                              ---------------------
             (Exact name of registrant as specified in its charter)


           Florida                                             59-2181303     
           -------                                             ----------     
(State or other jurisdiction of                             (I.R.S. Employer
 incorporation or organization)                           Identification Number)


930 N.W. 8th Avenue, Gainesville, Florida                        32601      
-----------------------------------------                        -----      
(Address of principal executive offices)                       (Zip Code)


                                 (352) 375-0607
                                 --------------
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed  by  section  13 or 15 (d) of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past ninety days. Yes X  No

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date:

                                          Number of shares outstanding on
                                          Feb. 28, 1999
                                          -------------

                                          100,352,500 shares of which
                                          7,408,500 are treasury shares
TITLE OF EACH CLASS
-------------------
Common stock $.0001 par value


The total number of pages of this report is 11.


<PAGE>

                              Mammatech Corporation

                                      INDEX

PART I.

     FINANCIAL INFORMATION                                     PAGE NO.


         Item 1.  Financial Statements

         Statements of Operations for Three Months
         Ended Feb. 28, 1999 and Feb. 28, 1998....................3

         Balance Sheets for Feb. 28, 1999 and
         August 31, 1998........................................4-5

         Statement of Cash Flow for the Six Months
         Ended Feb. 28, 1998......................................6

         Statement of Cash Flow for the Six Months
         Ended Feb. 28, 1999......................................7

         Notes to Financial Statements for the Quarter
         Ended Feb. 28, 1999......................................8


         Item 2.  Management's Discussion and Analysis of
         Financial Conditions and Results of Operations...........9


PART II. OTHER INFORMATION


         Item 6.  Exhibits and Reports on Form 8-K...............10

         SIGNATURES............................................. 11


                                       2
<PAGE>
<TABLE>
<CAPTION>


                                            Mammatech Corporation
                                          Statements of Operations
                                                  (Unaudited)

==============================================================================================================
                                                      Six Months Ended               Three Months Ended
                                               ------------------------------   ------------------------------
                                               February 1999    February 1998   February 1999    February 1998
                                               -------------    -------------   -------------    -------------
<S>                                            <C>              <C>             <C>              <C>          
Sales, net                                     $     203,200    $     222,479   $      67,568    $      47,467

Cost of sales                                         72,843           64,134          22,279           16,208

Gross Profit                                         130,357          158,345          45,289           31,258

Selling, General and Administrative Expenses         196,754          154,440          86,829           74,534

Operating gain (loss)                                (66,397)           3,905         (41,540)         (43,276)


Other Income (SBIR)                                   89,545           65,391          32,543           39,084
Interest and dividends                                12,817            8,487           6,006            4,645
                                               -------------    -------------   -------------    -------------
                                                     102,362           74,178          38,549           43,759

Net income before taxes                               35,965           77,783          (2,991)             453

Provision for income tax                                 -0-              -0-             -0-              -0-

Net Income (loss)                                     35,965           77,783          (2,991)             453

Net Income (loss) per share                              .00              .00             .00              .00

Weighted average shares                          100,352,500      100,352,500     100,352,500      100,352,500
==============================================================================================================



The accompanying notes are an integral part of the financial statements.

                                       3
</TABLE>
 
<PAGE>

                              Mammatech Corporation

                                 Balance Sheets

                                                      Feb. 28,          Aug. 31,
                                                        1999             1998
                                                     (Unaudited)       (Audited)
                                                      --------         --------
ASSETS
------

  Cash and Cash Equivalents                           $403,829         $342,740
   Marketable securities                               106,445           94,377

  Accounts receivable:
    Trade                                               33,926           74,983
    Other                                                3,190            3,190
  Inventory                                            209,122          201,574
  Other current assets                                    --               --

  Total Current Assets                                 756,512          716,864

Property and equipment                                  40,102           43,622

Other assets:


  Patents, trademarks, and
    other intangibles, net of
    accumulated amortization
    of $53,080 and $46,942
    respectively                                         7,392            8,657


Total other assets                                       7,392            8,657
                                                      --------         --------

TOTAL ASSETS                                          $804,006         $769,143
                                                      ========         ========



The accompanying notes are an integral part of the financial statements.


                                       4

<PAGE>

                      Mammatech Corporation Balance Sheets
                             As of August 31, 1998
                                and Feb. 28, 1999
                                   (continued)

                                                  Feb. 1999          Aug. 1998
                                                  ---------          ---------

LIABILITIES AND STOCKHOLDERS' EQUITY
------------------------------------

CURRENT LIABILITIES
-------------------
Accounts payable-trade                            $    32,345       $    48,595
Accrued payable-officer                                 6,630             6,630
Short Term debt                                         4,796             4,796
Accrued expenses                                      168,653           163,966
                                                  -----------       -----------

TOTAL CURRENT LIABILITIES                             212,425           223,987
                                                  -----------       -----------


COMMITMENTS
Long Term Debt                                          1,940             1,940
Stockholders' equity:

  Common stock, par value $.0001;
  200,000,000 shares authorized;
  100,352,500 shares issued
  and outstanding                                 $    10,035       $    10,035

  Additional paid-in capital                        2,809,594         2,809,594
  Accumulated deficit                              (2,094,006)       (2,109,926
                                                  -----------       -----------
                                                      725,623           709,703
  Valuation allowance for
  marketable securities                                12,068           (18,436)

  Treasury stock at cost,
  6,208,500 shares                                   (148,051)         (148,051)
                                                  -----------       -----------
                                                      589,640           543,216
                                                  -----------       -----------

TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY                              $   804,005       $   769,143
                                                  ===========       ===========


The accompanying notes are an integral part of these statements.


                                       5

<PAGE>


                              Mammatech Corporation
                             Statement of Cash Flow
                            For the Six Months Ending
                                  Feb. 28, 1999



Net cash flow from operating activities                                 $ 57,569
                                                                        ========

Investing Activities:
    Purchase of furniture and fixtures                                     3,520


Financing activities:
    Issuance of treasury shares                                              -0-
Sale of marketable securities                                                -0-

Net increase (decrease) in cash                                           61,089

Beginning cash                                                           342,740
                                                                        --------

Ending cash                                                              403,829
                                                                        ========



The accompanying notes are an integral part of the financial statements.

                                       6
<PAGE>


                              Mammatech Corporation
                             Statement of Cash Flow
                            For the Six Months Ending
                                  Feb. 28, 1998



Net cash flow from operating activities                                 $ 86,216
                                                                        ========

Investing Activities:
    Purchase of furniture and fixtures                                     3,280


Financing activities:
    Issuance of treasury shares                                              -0-
Sale of marketable securities                                                -0-

Net increase (decrease) in cash                                           89,496

Beginning cash                                                           169,088
                                                                        --------

Ending cash                                                              258,370
                                                                        ========



The accompanying notes are an integral part of the financial statements.

                                        7

<PAGE>

                              Mammatech Corporation
                          Notes to Financial Statements
                                  Feb. 28, 1999



Note 1.   In the opinion of the Company,  the accompanying  unaudited  financial
          statements   contain  all  adjustments   (consisting  of  only  normal
          recurring accruals) necessary to present fairly the financial position
          as of Feb.  28,  1999,  and the results of  operations  and changes in
          financial position for the three months ended Feb. 28, 1999.


Note 2.   Loss per  share is based on the  weighted  average  number  of  shares
          outstanding during each period.




                                       8

<PAGE>


MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITIONS AND RESULTS OF OPERATION FOR MAMMATECH CORPORATION


The second  quarter of fiscal 1999 was a period of  transition  for the Company.
Sales revenues  increased by 42.3% from the same period a year ago, but declined
50.2% in comparison to the previous quarter.  Similarly,  gross profit increased
37.6% from the second  quarter of 1998,  but  decreased by 75% in  comparison to
last quarter. Operating expense during the current quarter relative to the first
quarter  decreased  by 21%, but  increased  by 16.5% over the second  quarter of
1998.  The was a small  net loss for the  quarter  due  primarily  to  increased
expense  associated  with expansion of the  professional  training  program (see
below).

A similar picture emerges with respect to the six-month figures.  Sales revenues
declined by 8.79% while  operating  expense  increased by 27.4%  compared to the
first  six  months  of  1997.  The net  result  for the  first  half of the year
therefore shows a decline of 53.8% compared to the comparable period a year ago.

The decline in sales revenues reported here is attributed to two factors: First,
there have been no major purchases by military  installations as there were last
year.  Second,  foreign sales are somewhat depressed with absolutely no activity
on the part of our Brazilian distributor.  Sales in Germany continue at a stable
rate,  however.  Fortunately,  the State of  Montana  made a major  purchase  in
connection with its BCCP Program funded by the Center for Disease Control.

The Company is focusing  substantial  effort and resources on strengthening  its
Professional Training Program. A manuscript describing the major elements of the
expanded  program was submitted and accepted for Fall publication in a respected
medical  journal.  Also during the quarter,  eleven  MammaCare  Specialists were
trained by the new Training  Directors who were hired during the first  quarter.
During the same period last year, five  Specialists  were trained.  Moreover,  a
number of the  individuals  trained  this year are  members  of the  faculty  of
academic  medical  centers,  so MammaCare  training  and product  sales might be
expected to continue in those  settings.  There can, of course,  be no assurance
that such activity will materialize or that substantial  revenues to the Company
will result.

In spite of a  substantial  increase in the training  fees,  bookings for future
courses are expanding rapidly.  Further expansion of this program is expected as
a result of a marketing presence at selected  conferences although it remains to
be  demonstrated  that  sufficient  revenue  will  result to offset the  expense
associated with attending such events.


The  Company  remains  essentially  debt  free  and has no  immediate  liquidity
problems.  It continues to seek other  opportunities to expand its marketing and
manufacturing  activities  to  meet  the  growing  world-wide  interest  in  its
products.

                                       9

<PAGE>


PART II - OTHER INFORMATION
---------------------------



Item 6.   Exhibits and Reports on Form 8-K

     (a.) Exhibits - None

     (b.) There were no reports filed on Form 8-K during the three months ending
          Feb. 28, 1999.



                                       10
<PAGE>


                                      10-Q

                    For the three months ended Feb. 28, 1999

                                   Signatures

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

MAMMATECH CORPORATION
---------------------

DATE: April 12, 1999                 BY: /s/ Henry S. Pennypacker
     ---------------------           -----------------------------
                                     Henry S. Pennypacker,
                                     President and Director

BY: /s/ Mary Sellers
   -----------------------------
   Mary Sellers, Treasurer and
   Chief Financial Officer


                                       11